Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth.

Abstract:

:Increased matrix metalloproteinase-1 (MMP-1) expression is associated with advanced stages of breast cancer and may be a predictive marker for the development of invasive disease. In this report, we used short hairpin RNA (shRNA) molecules to investigate whether MMP-1 production in MDA-231 breast cancer cells contributed to the degradation of a collagen matrix or tumor formation in nude mice. We created two groups of MDA-231 cell lines. MDA-231 cells containing a vector producing shRNA specific for MMP-1 had a >90% decrease in MMP-1 mRNA and protein compared with cells containing an empty vector, and blocking MMP-1 expression inhibited the in vitro collagenolytic activity of MDA-231 cells. When the cells were injected into the mammary fat pad, there was no difference in the frequency of tumor formation in mice. However, the average tumor size was larger in mice injected with cells containing the empty vector (1,216 +/- 334 mm3) than in mice injected with cells expressing the MMP-1 shRNA (272 +/- 117 mm3; P = 0.027). We conclude that MMP-1 expression is essential for the ability of MDA-231 cells to invade and destroy a collagen matrix and in vivo experiments suggest an important role for MMP-1 in breast tumor growth.

journal_name

Cancer Res

journal_title

Cancer research

authors

Wyatt CA,Geoghegan JC,Brinckerhoff CE

doi

10.1158/0008-5472.CAN-05-2446

subject

Has Abstract

pub_date

2005-12-01 00:00:00

pages

11101-8

issue

23

eissn

0008-5472

issn

1538-7445

pii

65/23/11101

journal_volume

65

pub_type

杂志文章
  • Thanatop: a novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase II.

    abstract::A series of nitrofuran-based compounds were identified as inhibitors of estrogen signaling in a cell-based, high-throughput screen of a diverse library of small molecules. These highly related compounds were subsequently found to inhibit topoisomerase II in vitro at concentrations similar to that required for the inhi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0393

    authors: Polycarpou-Schwarz M,Müller K,Denger S,Riddell A,Lewis J,Gannon F,Reid G

    更新日期:2007-05-01 00:00:00

  • DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors.

    abstract::We generated DNA expression vectors encoding the full-length neu cDNA (designated pNeuN), the neu extracellular domain (pNeuE), or the neu extracellular and transmembrane domains (pNeuTM). The 293 cells transfected with pNeuN or pNeuTM expressed the neu extracellular domain on the surface membrane, whereas 293 cells t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chen Y,Hu D,Eling DJ,Robbins J,Kipps TJ

    更新日期:1998-05-01 00:00:00

  • LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.

    abstract::The majority of patients with colon cancer will develop advanced disease, with the liver being the most common site of metastatic disease. Patients with increased numbers of tumor-infiltrating lymphocytes in primary colon tumors and liver metastases have improved outcomes. However, the molecular factors that could emp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1655

    authors: Qiao G,Qin J,Kunda N,Calata JF,Mahmud DL,Gann P,Fu YX,Rosenberg SA,Prabhakar BS,Maker AV

    更新日期:2017-04-15 00:00:00

  • Effect of antineoplastic agents on gamma-interferon production in human peripheral blood mononuclear cells.

    abstract::Since gamma-interferon (IFN-gamma) is a potent immunomodulator and patients receiving certain antineoplastic agents are at risk of unusual infections, we have determined the effect of certain antineoplastic agents on IFN-gamma production. Induction of peripheral blood mononuclear cells from normal donors in the presen...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cesario TC,Slater LM,Kaplan HS,Gupta S,Gorse GJ

    更新日期:1984-11-01 00:00:00

  • Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

    abstract::In most patients with chronic myeloid leukemia (CML), the disease can be kept under control using the BCR/ABL kinase inhibitor imatinib. Nevertheless, resistance or intolerance to imatinib and other BCR/ABL inhibitors may occur during therapy. Therefore, CML research is focusing on novel targets and targeted drugs. Po...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2181

    authors: Gleixner KV,Ferenc V,Peter B,Gruze A,Meyer RA,Hadzijusufovic E,Cerny-Reiterer S,Mayerhofer M,Pickl WF,Sillaber C,Valent P

    更新日期:2010-02-15 00:00:00

  • Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation.

    abstract::Hypoxia is considered to be a major cause of tumor radioresistance. Reoxygenation of previously hypoxic areas after a priming dose of radiation is associated with an increase in tumor radiosensitivity. In a study of a hypoxic mammary carcinoma, 31P nuclear magnetic resonance spectra showed statistically significant in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Koutcher JA,Alfieri AA,Devitt ML,Rhee JG,Kornblith AB,Mahmood U,Merchant TE,Cowburn D

    更新日期:1992-09-01 00:00:00

  • Heterogeneity in lineage derivation of Philadelphia-positive acute lymphoblastic leukemia expressing p190BCR-ABL or p210BCR-ABL: determination by analysis of individual colonies with the polymerase chain reaction.

    abstract::The molecular hallmark of Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) is the expression of 1 of 2 alternate forms of the aberrant BCR-ABL protein-p210BCR-ABL or p190BCR-ABL. The presence of BCR-ABL message provides a target for analyzing the lineage derivation of this disease. We, therefore, st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Estrov Z,Talpaz M,Kantarjian HM,Zipf TF,McClain KL,Kurzrock R

    更新日期:1993-07-15 00:00:00

  • Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

    abstract::The interleukin (IL)-13 receptor alpha2 (IL-13Ralpha2) chain is a primary binding and internalization subunit for a Th2-derived immune regulatory cytokine, IL-13. Although extremely high levels of IL-13Ralpha2 chain are expressed on a variety of human tumor cells and specimens, its precise role in tumor immunology has...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1265

    authors: Kawakami K,Terabe M,Kawakami M,Berzofsky JA,Puri RK

    更新日期:2006-04-15 00:00:00

  • Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer.

    abstract::Despite significant advances in cancer precision medicine, a significant hurdle to its broader adoption remains the multitude of variants of unknown significance identified by clinical tumor sequencing and the lack of biologically validated methods to distinguish between functional and benign variants. Here we used fu...

    journal_title:Cancer research

    pub_type: 评论,杂志文章

    doi:10.1158/0008-5472.CAN-20-0865

    authors: Hanrahan AJ,Sylvester BE,Chang MT,Elzein A,Gao J,Han W,Liu Y,Xu D,Gao SP,Gorelick AN,Jones AM,Kiliti AJ,Nissan MH,Nimura CA,Poteshman AN,Yao Z,Gao Y,Hu W,Wise HC,Gavrila EI,Shoushtari AN,Tiwari S,Viale A,Abd

    更新日期:2020-10-01 00:00:00

  • Serum protein reduction of the enhancement of methotrexate accumulation by vincristine and 4'-demethylepipodophyllotoxin in the Ehrlich ascites tumor cell in vitro.

    abstract::The Vinca alkaloid vincristine and the epipodophyllotoxin derivative teniposide significantly elevate steady state levels of methotrexate in the Ehrlich ascites tumor cell in vitro. However, the presence of circulating serum proteins compromises this drug-cell interaction. In the presence of bovine serum albumin, elev...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gewirtz DA

    更新日期:1985-12-01 00:00:00

  • Clinical pharmacokinetics of vinblastine by continuous intravenous infusion.

    abstract::Vinblastine (VLB) is moderately active clinically against advanced breast cancer. Since VLB is extensively taken up by platelets and thus only partially available to tumor cells, to enhance the therapeutic index of VLB we have therefore administered this agent by continuous i.v. infusion to patients with advanced brea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu K,Yap HY,Loo TL

    更新日期:1983-03-01 00:00:00

  • Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.

    abstract::Incidence of the loss of heterozygosity on chromosome 3p was evaluated using 7 polymorphic probes in 35 Japanese patients with sporadic renal cell carcinoma (RCC). Overall frequency of the loss of heterozygosity on 3p was 53%, representing 16 of 30 informative cases. Examination of the relationship between histopathol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ogawa O,Kakehi Y,Ogawa K,Koshiba M,Sugiyama T,Yoshida O

    更新日期:1991-02-01 00:00:00

  • Nitric oxide mediates Kupffer cell-induced reduction of mitochondrial energization in hepatoma cells: a comparison with oxidative burst.

    abstract::The metabolic changes in rat hepatoma cell line, AH70 cells, after coculturing with Kupffer cells were visualized using a silicon-intensified target camera and subsequent processing with a computer-assisted digital imaging processor. In cocultured tumor cells, nonactivated Kupffer cells reduced mitochondrial energizat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kurose I,Miura S,Fukumura D,Yonei Y,Saito H,Tada S,Suematsu M,Tsuchiya M

    更新日期:1993-06-01 00:00:00

  • Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.

    abstract::Mithramycin (MIT) and tolfenamic acid (TA) inhibit the activity of the transcription factor Sp1. In the present study, we investigated whether pancreatic cancer treatment with a combination of these compounds has a synergistic effect on Sp1 activity, tumor growth, and their underlying response mechanisms. Treatment of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3282

    authors: Jia Z,Gao Y,Wang L,Li Q,Zhang J,Le X,Wei D,Yao JC,Chang DZ,Huang S,Xie K

    更新日期:2010-02-01 00:00:00

  • Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells.

    abstract::Various hormones and growth factors are involved in the growth regulation of breast (tumor) cells. In this report we show for the first time that an analogue of the neuropeptide somatostatin (Sandostatin) can also influence the proliferation of human breast cancer cells (MCF-7), namely, in an inhibitory fashion. With ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Setyono-Han B,Henkelman MS,Foekens JA,Klijn GM

    更新日期:1987-03-15 00:00:00

  • p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.

    abstract::Structural alterations of the p53 gene were investigated in tissue specimens of gastric and cervical cancers and in cell lines of gastric, esophageal, and cervical cancers, by polymerase chain reaction-single-strand conformation polymorphism analysis. Two of the four gastric cancer metastases and four of the eight cel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yamada Y,Yoshida T,Hayashi K,Sekiya T,Yokota J,Hirohashi S,Nakatani K,Nakano H,Sugimura T,Terada M

    更新日期:1991-11-01 00:00:00

  • Cytoplasmic domain of proEGF affects distribution and post-translational modification of microtubuli and increases microtubule-associated proteins 1b and 2 production in human thyroid carcinoma cells.

    abstract::We studied the distribution of transcripts encoding the cytoplasmic domain of the membrane-anchored precursor epidermal growth factor (proEGFcyt) and a novel cytoplasmic proEGF splice isoform with a deleted exon 23 and an out-of-frame fusion of exon 24 (proEGFdel23) in human normal and neoplastic thyroid tissues. In p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2030

    authors: Pyka J,Glogowska A,Dralle H,Hoang-Vu C,Klonisch T

    更新日期:2005-02-15 00:00:00

  • Stimulation of tumor necrosis factor release from monocytic cells by the A375 human melanoma via granulocyte-macrophage colony-stimulating factor.

    abstract::It has long been known that complex interactions occur between tumors and normal host immune cells. The human melanoma cell line A375 has been used previously as an indicator cell for tumor cell cytotoxicity mediated by monocytes. During other studies on this tumor cell line, we noted that the conditioned media harves...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sabatini M,Chavez J,Mundy GR,Bonewald LF

    更新日期:1990-05-01 00:00:00

  • Effect of dietary 2(3)-tert-butyl-4-hydroxyanisole on the metabolism and action of estradiol and estrone in female CD-1 mice.

    abstract::Administration of 0.75% 2(3)-tert-butyl-4-hydroxyanisole (BHA) in AIN-76A diet to female CD-1 mice for 3 weeks increased liver microsomal glucuronidation of estradiol, estrone, 4-aminophenol, and 4-nitrophenol by 103, 187, 162, and 92%, respectively (at pH 7.4). The overall rate of NADPH-dependent metabolism of estrad...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zhu BT,Lech J,Rosen RT,Conney AH

    更新日期:1997-06-15 00:00:00

  • Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity.

    abstract::Ongoing clinical trials are exploring anticancer approaches based on signaling by TRAIL, a ligand for the cell death receptors DR4 and DR5. In this study, we report on the selective apoptotic effects of multivalent DR5 binding peptides (TRAIL(mim/DR5)) on cancer cells in vitro and in vivo. Surface plasmon resonance re...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2889

    authors: Pavet V,Beyrath J,Pardin C,Morizot A,Lechner MC,Briand JP,Wendland M,Maison W,Fournel S,Micheau O,Guichard G,Gronemeyer H

    更新日期:2010-02-01 00:00:00

  • LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors.

    abstract::We recently reported that LY294002 (LY29) and LY303511 (LY30) sensitized tumor cells to drug-induced apoptosis independent of the phosphoinositide 3-kinase/Akt pathway. Here, we investigated the mechanism of LY30-induced sensitization of human neuroblastoma cells to TRAIL-mediated apoptosis. We provide evidence that L...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1996

    authors: Shenoy K,Wu Y,Pervaiz S

    更新日期:2009-03-01 00:00:00

  • Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.

    abstract::Currently, no curative therapy for metastatic prostate cancer exists. Causing prostate cancer cells to express functionally active sodium iodide symporter (NIS) would enable those cells to concentrate iodide from plasma and might offer the ability to treat prostate cancer with radioiodine. Therefore, the aim of our st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Spitzweg C,Zhang S,Bergert ER,Castro MR,McIver B,Heufelder AE,Tindall DJ,Young CY,Morris JC

    更新日期:1999-05-01 00:00:00

  • From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells.

    abstract::Multiple myeloma (MM) is a treatable, but incurable, malignancy of plasma cells (PC) in the bone marrow (BM). It represents the final stage in a continuum of PC dyscrasias and is consistently preceded by a premalignant phase termed monoclonal gammopathy of undetermined significance (MGUS). The existence of this well-d...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-17-3115

    authors: van Nieuwenhuijzen N,Spaan I,Raymakers R,Peperzak V

    更新日期:2018-05-15 00:00:00

  • AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D.

    abstract::Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers largely due to disseminated disease at the time of presentation. Here, we investigated the role and mechanism of action of the metastasis-associated protein anterior gradient 2 (AGR2) in the pathogenesis of pancreatic cancer. AGR2 was induc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-1367

    authors: Dumartin L,Whiteman HJ,Weeks ME,Hariharan D,Dmitrovic B,Iacobuzio-Donahue CA,Brentnall TA,Bronner MP,Feakins RM,Timms JF,Brennan C,Lemoine NR,Crnogorac-Jurcevic T

    更新日期:2011-11-15 00:00:00

  • eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.

    abstract::Inhibition of the survival kinase Akt can trigger apoptosis, and also has been found to activate autophagy, which may confound tumor attack. In this study, we investigated regulatory mechanisms through which apoptosis and autophagy were modulated in tumor cells subjected to Akt inhibition by MK-2206, the first alloste...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2889

    authors: Cheng Y,Ren X,Zhang Y,Patel R,Sharma A,Wu H,Robertson GP,Yan L,Rubin E,Yang JM

    更新日期:2011-04-01 00:00:00

  • Age-related differences in the trends of fatal Hodgkin's disease as a consequence of immune experience.

    abstract::It has been proposed by MacMahon, on the basis of the variations among populations in the age distribution of fatal Hodgkin's disease, that there are two etiological factors, one important in young adults and the other important in middle-aged and elderly people. Correa has extended this by suggesting that those who d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Szekely DR,Lee JA

    更新日期:1977-12-01 00:00:00

  • Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.

    abstract::The AP-2 transcription factors are required for normal growth and morphogenesis during mammalian development. Previous in vitro studies have also indicated that the AP-2 family of proteins may be involved in the etiology of human breast cancer. The AP-2 genes are expressed in many human breast cancer cell lines, and c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Turner BC,Zhang J,Gumbs AA,Maher MG,Kaplan L,Carter D,Glazer PM,Hurst HC,Haffty BG,Williams T

    更新日期:1998-12-01 00:00:00

  • Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.

    abstract::The tumor suppressor phosphatase and tensin homologue (PTEN) is involved in cell proliferation, adhesion, and apoptosis. PTEN overexpression in mammary epithelium leads to reduced cell number and impaired differentiation and secretion. In contrast, overexpression of the proto-oncogene Wnt-1 in mammary epithelium leads...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0181

    authors: Zhao H,Cui Y,Dupont J,Sun H,Hennighausen L,Yakar S

    更新日期:2005-08-01 00:00:00

  • EZH2 is essential for glioblastoma cancer stem cell maintenance.

    abstract::Overexpression of the polycomb group protein enhancer of zeste homologue 2 (EZH2) occurs in diverse malignancies, including prostate cancer, breast cancer, and glioblastoma multiforme (GBM). Based on its ability to modulate transcription of key genes implicated in cell cycle control, DNA repair, and cell differentiati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1622

    authors: Suvà ML,Riggi N,Janiszewska M,Radovanovic I,Provero P,Stehle JC,Baumer K,Le Bitoux MA,Marino D,Cironi L,Marquez VE,Clément V,Stamenkovic I

    更新日期:2009-12-15 00:00:00

  • Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.

    abstract::While antiestrogens are useful agents in the treatment of breast cancer, the usefulness of these agents in the treatment of endometrial cancer remains controversial. There is some concern that the currently available antiestrogens may have partial agonist activity in uterine tissue. To better understand the mechanisms...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gong Y,Ballejo G,Murphy LC,Murphy LJ

    更新日期:1992-04-01 00:00:00